Introduction
Multidrug-resistant (MDR) Acinetobacter baumannii are associated with a wide spectrum of infectious diseases, ranging from nosocomial and community-acquired infections to those acquired in natural disasters or war. 1 The main mechanism of resistance to carbapenems in A. baumannii is the production of acquired OXAtype carbapenemases, encoded mostly by bla OXA-23-like , bla OXA-24-like , and bla OXA-58-like genes, which have been identified frequently worldwide. 1 In 2008, New Delhi metallo-b-lactamase 1 (NDM-1), encoded by the bla NDM-1 gene and conferring resistance to all the b-lactams including carbapenems, was discovered in Enterobacteriaceae isolates isolated in Sweden from a patient hospitalized in India. 2 Since this first description, the enzyme has been reported throughout the world as an emerging carbapenemase widely detected in clinical Enterobacteriaceae, but also in A. baumannii, in which the bla NDM-1 and bla NDM-2 genes have recently been identified.
and resistance to carbapenems (imipenem, meropenem, and doripenem) was confirmed by Etest diffusion (bioMé rieux, Marcy l'Etoile, France).
PCR assays and molecular typing
Real-time PCR was done to screen for the presence of bla OXA-23-like , bla OXA-24-like , bla OXA-58-like , and bla OXA-143-like genes. 5 The presence of bla NDM genes was investigated by standard PCR amplification. Sequencing of the entire carbapenem resistance gene was performed.
Genotyping was performed by pulsed-field gel electrophoresis (PFGE) using ApaI enzyme and multilocus sequence typing (MLST), in accordance with the Pasteur Institute instructions (http:// www.pasteur.fr/mlst). Moreover, the bla OXA-51-like gene was sequenced and compared to all identified variants.
Results and discussion
The carbapenem-resistant A. baumannii presented here were isolated from civilians wounded in 2012 during the Syrian war and admitted to the government hospital of Kobbe, Tripoli, in northern Lebanon ( Table 1 ). The four isolates had high-level resistance to carbapenems since the minimum inhibitory concentrations (MICs) for imipenem, meropenem, and doripenem were >32 mg/l. The isolates were also resistant to fluoroquinolones, but remained susceptible to aminoglycosides, doxycycline, tigecycline, rifampin, and colistin. They all carried the bla NDM gene and were negative for the other carbapenem resistance genes tested. Sequencing of the bla NDM gene showed that the variant was the bla NDM-1 gene in all four isolates.
Multidrug-resistant and bla NDM-1 gene-carrying A. baumannii are increasingly reported worldwide. Since 2010, they have been identified in various parts of the world, in particular in North Africa and the Middle East, 6 but to our knowledge, this is the first report of carbapenem-resistant A. baumannii carrying the bla NDM-1 gene in Lebanon. However, two NDM-1-producing Klebsiella pneumoniae imported from Iraq were detected in 2010. 7 To date, no NDM-1-producing A. baumannii has been described in Syria; however this is a country where data on the prevalence of A. baumannii antibiotic resistance remain limited. Recently, Hamzeh et al. published a report in which 260 A. baumannii isolates isolated from patients hospitalized in the area of Aleppo were studied. 8 They showed that 66% of the isolates were resistant to carbapenems, but no further molecular epidemiological studies to explore resistance mechanisms were performed. Outbreaks of MDR A. baumannii infections have been reported previously during war, as shown by Scott et al. and Kusradze et al., who studied the bacteria isolated in US service members injured in Iraq. 9, 10 However, no isolate harbouring a bla NDM-1 gene was found among the casualties. Although a majority of NDM-1-producing A. baumannii are isolated in the hospital setting, it is possible that the bacterium can be isolated from various environmental locations worldwide, even if the reservoir of such MDR isolates is not yet well known. In the present study, the origin of the A. baumannii infection in injured patients was difficult to determine. We were unable to obtain information on the date of injury, conditions of care, or on the treatment administered in Syria. The infection may have been acquired from environmental sources on the battlefield, during the patient's stay in Syrian clinics, or during evacuation from the operation theatre to Lebanon. The PFGE analysis showed that the four isolates shared identical patterns. The MLST analysis showed that all isolates belonged to sequence type 85 (ST85), and sequencing of the bla OXA-51-like gene identified bla OXA-94 as a unique variant. Reports of ST85-type strains worldwide are rare. Two A. baumannii belonging to the ST85 clone and carrying the bla NDM-1 gene have recently been described in France. Those strains were isolated from rectal swabs and harboured the bla OXA-94 variant. 6 In conclusion, this study reports the spread of NDM-1-producing A. baumannii in Syria, showing that this country constitutes a reservoir for NDM-1-producing bacteria. This information is of major importance, since because of the civil war, many injured people are being transferred to foreign hospitals for treatment. Among these hospitals, those in Lebanon are the first affected. These results highlight the importance of implementing effective infection control measures to stop the threatening spread of such resistant microorganisms. 
